Evidence map›Paper›PMID 30808763›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Katrin Unterhauser, Lisa Pöltl, Georg Schneditz, Sabine Kienesberger, Ronald A Glabonjat, Maksym Kitsera, Jakob Pletz, Fernando Josa-Prado, Elisabeth Dornisch, Christian Lembacher-Fadum and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 77 citations in OpenAlex.

  1. Novel bacteriumGut microbes · 2026
    Article
  2. Article
  3. Review
  4. Harnessing the microbiome for cancer therapy.Nature reviews. Microbiology · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 2 countries.

Katrin UnterhauserInstitute of Molecular Biosciences, University of Graz, A-8010 Graz, Austria.
Lisa PöltlInstitute of Molecular Biosciences, University of Graz, A-8010 Graz, Austria.
Georg SchneditzInstitute of Molecular Biosciences, University of Graz, A-8010 Graz, Austria.ORCID 0000-0001-6734-5861
Sabine KienesbergerInstitute of Molecular Biosciences, University of Graz, A-8010 Graz, Austria.
Ronald A GlabonjatInstitute of Chemistry, University of Graz, A-8010 Graz, Austria.
Maksym KitseraInstitute of Molecular Biosciences, University of Graz, A-8010 Graz, Austria.ORCID 0000-0003-1214-1313
Jakob PletzInstitute of Chemistry, University of Graz, A-8010 Graz, Austria.
Fernando Josa-PradoCentro de Investigaciones Biológicas, Consejo Superior de Investigaciones Scientíficas (CIB-CSIC), 28040 Madrid, Spain.
Elisabeth DornischInstitute of Molecular Biosciences, University of Graz, A-8010 Graz, Austria.
Christian Lembacher-FadumInstitute of Organic Chemistry, Graz University of Technology, A-8010 Graz, Austria.
Sandro RoierInstitute of Molecular Biosciences, University of Graz, A-8010 Graz, Austria.
Gregor GorkiewiczBioTechMed-Graz, A-8010 Graz, Austria.
Daniel LucenaCentro de Investigaciones Biológicas, Consejo Superior de Investigaciones Scientíficas (CIB-CSIC), 28040 Madrid, Spain.
Isabel BarasoainCentro de Investigaciones Biológicas, Consejo Superior de Investigaciones Scientíficas (CIB-CSIC), 28040 Madrid, Spain.
Wolfgang KroutilInstitute of Chemistry, University of Graz, A-8010 Graz, Austria.
Marc WiednerCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, A-1090 Vienna, Austria.
Joanna I LoizouCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, A-1090 Vienna, Austria.
Rolf BreinbauerInstitute of Organic Chemistry, Graz University of Technology, A-8010 Graz, Austria.
José Fernando DíazCentro de Investigaciones Biológicas, Consejo Superior de Investigaciones Scientíficas (CIB-CSIC), 28040 Madrid, Spain.
Stefan SchildInstitute of Molecular Biosciences, University of Graz, A-8010 Graz, Austria.ORCID 0000-0001-7842-0177
Christoph HögenauerBioTechMed-Graz, A-8010 Graz, Austria.
Ellen L ZechnerInstitute of Molecular Biosciences, University of Graz, A-8010 Graz, Austria; ellen.zechner@uni-graz.at.ORCID 0000-0003-2035-1898
University of Graz · ATCentro de Investigaciones Biológicas Margarita Salas · ESAustrian Academy of Sciences · ATGraz University of Technology · ATMedical University of Graz · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Establishing causal links between bacterial metabolites and human intestinal disease is a significant challenge. This study reveals the molecular basis of antibiotic-associated hemorrhagic colitis (AAHC) caused by intestinal resident

Indexed as

AnimalsBenzodiazepinonesDNA DamageEnterocolitis, PseudomembranousEnterotoxinsEpithelial CellsHost Microbial InteractionsHumansIntestinesKlebsiella InfectionsKlebsiella oxytocaMiceMicrotubulesOxyquinolinePeptides5-methyl-8-hydroxyquinolineBenzodiazepinonesEnterotoxinsOxyquinolinePeptidestilivallineantibiotic-induced diarrheaDNA damagedysbiosisintestinal microbiotatubulin inhibitor

Identifiers

PMID30808763
PMCPMC6397511
OpenAlexW2914541580

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.